Vallelian, F., Pfefferlé, M., Dubach, I. L., Buzzi, R. M., Dürst, E., Schulthess-Lutz, N., . . . Schaer, D. J. Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity. BMJ Publishing Group.
Chicago Style (17th ed.) CitationVallelian, Florence, et al. Antibody-induced Erythrophagocyte Reprogramming of Kupffer Cells Prevents Anti-CD40 Cancer Immunotherapy-associated Liver Toxicity. BMJ Publishing Group.
MLA (9th ed.) CitationVallelian, Florence, et al. Antibody-induced Erythrophagocyte Reprogramming of Kupffer Cells Prevents Anti-CD40 Cancer Immunotherapy-associated Liver Toxicity. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.